WATERLOO, Belgium, May 13, 2010 /PRNewswire/ --
- State-of-the-Art Irrigated Ablation Catheter Offers a Unique Design and Industry Leading Cooling Efficiency
Biosense Webster, Inc., a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today the completion of the first clinical cases with the new THERMOCOOL(R) SF Irrigated Ablation catheter in the European Union, following recent CE Mark approval. The THERMOCOOL(R) SF catheter is the most advanced Biosense Webster irrigated ablation catheter for use by electrophysiologists in treating cardiac arrhythmias, commonly referred to as irregular heart rhythms.
The THERMOCOOL (R) SF Irrigated catheter is the next generation in irrigated ablation catheters and builds upon the industry leading THERMOCOOL(R) irrigated catheter platform. The THERMOCOOL (R) SF catheter's unique design and porous tip technology provides EPs with uniform cooling across the entire catheter tip and allows efficient cooling at half the flow rate.
"The THERMOCOOL(R) SF Irrigated Catheter is the latest advancement in irrigated ablation catheter design with its groundbreaking and unique porous tip technology," said Shlomi Nachman, Worldwide President, Biosense Webster, Inc. "This innovation further builds upon our clear leadership position in the electrophysiology market and reinforces our long-standing commitment to electrophysiologists and their patients. "We are extremely pleased this exciting new product will be launched throughout the European Union over the coming months."
Unlike competitive irrigated technologies which offer localized cooling, the cutting edge catheter design and breakthrough porous tip technology of the